Bioavailability and Bioequivalence * *Disclaimer: The chapter reflects the views of the authors and should not be construed to represent the views or policies of the Food and Drug Administration (FDA). No official endorsement by the FDA is intended or should be inferred.-Reference-Cited by-同舟云学术

Bioavailability and Bioequivalence * *Disclaimer: The chapter reflects the views of the authors and should not be construed to represent the views or policies of the Food and Drug Administration (FDA). No official endorsement by the FDA is intended or should be inferred.

Published:2017 Issue: Volume: Page:381-397
ISSN:
Container-title:Developing Solid Oral Dosage Forms
language:
Short-container-title:

Author:

Zhu H.,Li B.V.,Uppoor R.S.,Mehta M.,Yu L.X.

Publisher

Elsevier

Reference67 articles.

1. FDA. Draft guidance for industry: bioavailability and bioequivalence studies submitted in NDAs or INDs—general considerations. ; 2014 [accessed 21.05.15].

2. FDA. Guidance for industry: food-effect bioavailability and fed bioequivalence studies. ; 2002 [accessed 21.05.15].

3. pH-dependent drug-drug interactions for weak base drugs: potential implications for new drug development;Zhang;Clin Pharmacol Ther,2014

4. FDA. Guidance for industry: bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA. ; 2013 [accessed 21.05.15].

5. Variation in biologic availability of digoxin from four preparations;Lindenbaum;N Engl J Med,1971

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial Membrane Vesicles as Smart Drug Delivery and Carrier Systems: A New Nanosystems Tool for Current Anticancer and Antimicrobial Therapy;Pharmaceutics;2023-03-24

2. Intestinal Drug Absorption Enhancement by Aloe vera Gel and Whole Leaf Extract: In Vitro Investigations into the Mechanisms of Action;Pharmaceutics;2019-01-18